Referral to Palliative Care Infrequent in Patients with Idiopathic Pulmonary Fibrosis Admitted to an Intensive Care Unit

Journal of Palliative Medicine

Volumn 20, Issue 2, 2017, Pages 134-140

  Liang, Zhan ^a   Hoffman, Leslie A ^b   Nouraie, Mehdi ^c   Kass, Daniel J ^c   Donahoe, Michael P ^c   Gibson, Kevin F ^c   Saul, Melissa I ^c   Lindell, Kathleen O ^c  

^a UNIVERSITY OF SOUTH FLORIDA   (United States)

^b UNIVERSITY OF PITTSBURGH   (United States)

^c UNIVERSITY OF PITTSBURGH SCHOOL OF MEDICINE   (United States)

Author keywords

advanced care planning; idiopathic pulmonary fibrosis; intensive care unit; palliative care

Indexed keywords

CARBON MONOXIDE;

AGED; ARTICLE; CLINICAL FEATURE; DETERIORATION; FEMALE; FIBROSING ALVEOLITIS; FORCED VITAL CAPACITY; FREQUENCY; HOSPITAL ADMISSION; HUMAN; INTENSIVE CARE UNIT; LUNG DIFFUSION CAPACITY; MAJOR CLINICAL STUDY; MALE; PALLIATIVE THERAPY; PATIENT REFERRAL; RETROSPECTIVE STUDY; SURVIVAL; CLINICAL AUDIT; HOSPITALIZATION; MIDDLE AGED; UTILIZATION;

AGED; FEMALE; HOSPITALIZATION; HUMANS; IDIOPATHIC PULMONARY FIBROSIS; INTENSIVE CARE UNITS; MALE; MEDICAL AUDIT; MIDDLE AGED; PALLIATIVE CARE; REFERRAL AND CONSULTATION; RETROSPECTIVE STUDIES;

EID: 85009785976     PISSN: 10966218     EISSN: 15577740     Source Type: Journal    
DOI: 10.1089/jpm.2016.0258     Document Type: Article

References (34)

1. Raghu G, Collard HR, Egan JJ, et al.: An official ATS/ERS/JRS/ALAT statement: Idiopathic pulmonary fibrosis: Evidence-based guidelines for diagnosis and management. Am J Respir Crit Care Med 2011;183:788-824.
2. Oldham JM, Noth I: Idiopathic pulmonary fibrosis: Early detection and referral. Respir Med 2014;108:819-829.
3. Raghu G, Chen SY, Yeh WS, et al.: Idiopathic pulmonary fibrosis in US Medicare beneficiaries aged 65 years and older: Incidence, prevalence, and survival, 2001-2011. Lancet Respir Med 2014;2:566-572.
4. Ley B, Collard HR, King TE, Jr.: Clinical course and prediction of survival in idiopathic pulmonary fibrosis. Am J Respir Crit Care Med 2011;183:431-440.
5. King TE, Jr., Bradford WZ, Castro-Bernardini S, et al.: A phase 3 trial of pirfenidone in patients with idiopathic pulmonary fibrosis. N Engl J Med 2014;370:2083-2092.
6. Richeldi L, du Bois RM, Raghu G, et al.: Efficacy and safety of nintedanib in idiopathic pulmonary fibrosis. N Engl J Med 2014;370:2071-2082.
7. Gottlieb J: Lung transplantation for interstitial lung diseases. Curr Opin Pulm Med 2014;20:457-462.
8. Bajwah S, Higginson IJ, Ross JR, et al.: The palliative care needs for fibrotic interstitial lung disease: A qualitative study of patients, informal caregivers and health professionals. Palliat Med 2013;27:869-876.
9. Brown CE, Jecker NS, Curtis JR: Inadequate palliative care in chronic lung disease. An issue of health care inequality. Ann Am Thorac Soc 2016;13:311-316.
10. Lindell KO, Liang Z, Hoffman LA, et al.: Palliative care and location of death in decedents with idiopathic pulmonary fibrosis. Chest 2015;147:423-429.
11. Wachterman MW, Pilver C, Smith D, et al.: Quality of endof-life care provided to patients with different serious illnesses. JAMA Intern Med 2016;176:1095-1102.
12. Beernaert K, Cohen J, Deliens L, et al.: Referral to palliative care in COPD and other chronic diseases: A population-based study. Respir Med 2013;107:1731-1739.
13. Brown CE, Engelberg RA, Nielsen EL, et al.: Palliative care for patients dying in the intensive care unit with chronic lung disease compared with metastatic cancer. Ann Am Thorac Soc 2016;13:684-689.
14. Saydain G, Islam A, Afessa B, et al.: Outcome of patients with idiopathic pulmonary fibrosis admitted to the intensive care unit. Am J Respir Crit Care Med 2002;166:839-842.
15. Mallick S: Outcome of patients with idiopathic pulmonary fibrosis (IPF) ventilated in intensive care unit. Respir Med 2008;102:1355-1359.
16. Vianello A, Arcaro G, Battistella L, et al.: Noninvasive ventilation in the event of acute respiratory failure in patients with idiopathic pulmonary fibrosis. J Crit Care 2014; 29:562-567.
17. Gaudry S, Vincent F, Rabbat A, et al.: Invasive mechanical ventilation in patients with fibrosing interstitial pneumonia. J Thorac Cardiovasc Surg 2014;147:47-53.
18. Rush B, Wiskar K, Berger L, et al.: The use of mechanical ventilation in patients with idiopathic pulmonary fibrosis in the United States: A nationwide retrospective cohort analysis. Respir Med 2016;111:72-76.
19. Khandelwal N, Kross EK, Engelberg RA, et al.: Estimating the effect of palliative care interventions and advance care planning on ICU utilization: A systematic review. Crit Care Med 2015;43:1102-1111.
20. Ley B, Ryerson CJ, Vittinghoff E, et al.: A multidimensional index and staging system for idiopathic pulmonary fibrosis. Ann Intern Med 2012;156:684-691.
21. Collard HR, Ryerson CJ, Corte TJ, et al.: Acute exacerbation of idiopathic pulmonary fibrosis. An International Working Group Report. Am J Respir Crit Care Med 2016; 194:265-275.
22. Lamas DJ, Kawut SM, Bagiella E, et al.: Delayed access and survival in idiopathic pulmonary fibrosis: A cohort study. Am J Respir Crit Care Med 2011;184:842-847.
23. King TE, Jr., Tooze JA, Schwarz MI, et al.: Predicting survival in idiopathic pulmonary fibrosis: Scoring system and survival model. Am J Respir Crit Care Med 2001;164: 1171-1181.
24. Ley B, Bradford WZ, Vittinghoff E, et al.: Predictors of mortality poorly predict common measures of disease progression in idiopathic pulmonary fibrosis. Am J Respir Crit Care Med 2016;194:711-718.
25. Salisbury ML, Xia M, Zhou Y, et al.: Idiopathic pulmonary fibrosis: Gender-age-physiology index stage for predicting future lung function decline. Chest 2016;149: 491-498.
26. Richards TJ, Kaminski N, Baribaud F, et al.: Peripheral blood proteins predict mortality in idiopathic pulmonary fibrosis. Am J Respir Crit Care Med 2012;185:67-76.
27. Swigris JJ, Kuschner WG, Jacobs SS, et al.: Health-related quality of life in patients with idiopathic pulmonary fibrosis: A systematic review. Thorax 2005;60:588-594.
28. Bernacki RE, Block SD, American College of Physicians High Value Care Task Force: Communication about serious illness care goals: A review and synthesis of best practices. JAMA Intern Med 2014;174:1994-2003.
29. Boland J, Martin J, Wells AU, et al.: Palliative care for people with non-malignant lung disease: Summary of current evidence and future direction. Palliat Med 2013;27:811-816.
30. Bajwah S, Ross JR, Wells AU, et al.: Palliative care for patients with advanced fibrotic lung disease: A randomised controlled phase II and feasibility trial of a community case conference intervention. Thorax 2015;70:830-839.
31. Dellon EP, Sawicki GS, Shores MD, et al.: Physician practices for communicating with patients with cystic fibrosis about the use of noninvasive and invasive mechanical ventilation. Chest 2012;141:1010-1017.
32. Temel JS, Greer JA, Muzikansky A, et al.: Early palliative care for patients with metastatic non-small-cell lung cancer. N Engl J Med 2010;363:733-742.
33. Coulourides Kogan A, Penido M, Enguidanos S: Does disclosure of terminal prognosis mean losing hope? Insights from exploring patient perspectives on their experience of palliative care consultations. J Palliat Med 2015;18:1019-1025.
34. Yoong J, Park ER, Greer JA, et al.: Early palliative care in advanced lung cancer: A qualitative study. JAMA Intern Med 2013;173:283-290.